down arrow

Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
120.00
3.55 (3.05%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
210.42
217.68
183.64
198.13
200.72
211.88
159.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
210.42
217.68
183.64
198.13
200.72
211.88
159.52
Raw Material Cost
97.41
100.01
98.48
87.28
90.97
89.57
71.29
Purchase of Finished goods
19.03
11.82
4.90
7.98
7.55
13.04
22.78
(Increase) / Decrease In Stocks
-2.25
3.09
-18.24
0.21
3.97
-2.88
-9.64
Employee Cost
29.76
27.51
26.54
24.51
24.29
23.26
23.52
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.00
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
36.67
33.76
37.63
49.80
30.25
34.51
27.36
Total Expenditure (Excl Depreciation)
180.63
176.20
149.31
169.78
157.03
157.51
135.31
Operating Profit (PBDIT) excl Other Income
29.79
41.48
34.33
28.35
43.69
54.37
24.21
Other Income
15.27
5.04
4.12
5.60
5.42
12.60
5.11
Operating Profit (PBDIT)
45.06
46.52
38.45
33.95
49.11
66.97
29.32
Interest
1.08
3.83
1.53
1.85
2.12
1.45
1.49
Exceptional Items
0.00
0.00
0.00
-29.20
0.00
0.00
0.00
Gross Profit (PBDT)
43.98
42.69
36.92
2.90
46.99
65.52
27.83
Depreciation
7.55
6.98
6.85
6.85
6.95
6.39
6.19
Profit Before Tax
36.42
35.71
30.07
-3.95
40.04
59.13
21.65
Tax
10.62
10.01
7.97
0.96
10.97
16.09
7.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.80
25.69
22.11
-4.91
29.07
43.04
14.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.80
25.69
22.11
-4.91
29.07
43.04
14.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.00
1.43
1.41
4.23
1.46
0.74
-0.31
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.80
24.26
20.70
-9.15
27.61
42.31
14.69
Equity Capital
10.54
10.51
10.49
10.47
10.47
10.44
10.42
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
2.26
2.31
1.97
-0.87
2.64
4.05
1.41
Diluted Earnings per share
2.27
2.29
1.93
-0.86
2.6
3.98
1.41
Operating Profit Margin (Excl OI)
14.16%
19.06%
18.69%
14.31%
21.77%
25.66%
15.18%
Gross Profit Margin
20.9%
19.61%
20.1%
1.46%
23.41%
30.92%
17.45%
PAT Margin
12.26%
11.8%
12.04%
-2.48%
14.48%
20.31%
9.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 4.83% vs -2.43% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2024 is -13.80% vs -1.18% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is -31.82% vs -8.39% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is -49.06% vs 68.25% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Bliss GVS Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
210.42
3,230.00
-3,019.58
-93.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
210.42
3,230.00
-3,019.58
-93.49%
Raw Material Cost
97.41
536.11
-438.70
-81.83%
Purchase of Finished goods
19.03
387.30
-368.27
-95.09%
(Increase) / Decrease In Stocks
-2.25
11.81
-14.06
-119.05%
Employee Cost
29.76
709.71
-679.95
-95.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
36.67
755.27
-718.60
-95.14%
Total Expenditure (Excl Depreciation)
180.63
2,400.20
-2,219.57
-92.47%
Operating Profit (PBDIT) excl Other Income
29.79
829.80
-800.01
-96.41%
Other Income
15.27
77.32
-62.05
-80.25%
Operating Profit (PBDIT)
45.06
907.12
-862.06
-95.03%
Interest
1.08
220.93
-219.85
-99.51%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
43.98
686.19
-642.21
-93.59%
Depreciation
7.55
192.30
-184.75
-96.07%
Profit Before Tax
36.42
497.33
-460.91
-92.68%
Tax
10.62
112.81
-102.19
-90.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
25.80
381.08
-355.28
-93.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
25.80
381.08
-355.28
-93.23%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
2.00
4.29
-2.29
-53.38%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.80
380.23
-356.43
-93.74%
Equity Capital
10.54
40.06
-29.52
-73.69%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.26
9.49
-7.23
-76.19%
Diluted Earnings per share
2.27
9.44
-7.17
-75.95%
Operating Profit Margin (Excl OI)
14.16%
25.69%
0.00
-11.53%
Gross Profit Margin
20.90%
21.24%
0.00
-0.34%
PAT Margin
12.26%
11.90%
0.00
0.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 210.42 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -3.34% vs 18.54% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 4.83% vs -2.43% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.80 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -1.90% vs 17.20% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -13.80% vs -1.18% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.79 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -28.18% vs 20.83% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -31.82% vs -8.39% in Dec 2023

Quarterly - Interest
Interest 1.08 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -71.80% vs 150.33% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -49.06% vs 68.25% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.16%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023